RxDoctor Payments Data

Alison Diesel, PA

Medical · Berlin, MDNPI 1871987818

Payments from drug & device makers

$1,053in general payments, 2019–2025

Across 54 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$165
  • Esperion Therapeutics, Inc.$107
  • Exact Sciences$92
  • GSK$88
  • AstraZeneca$72
  • Amgen$71
  • plus $458 from 13 others

What the payments were for

  • Food & beverage$1,01697%
  • Education$373%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,053 in reported general payments places this provider in the 65th percentile of 543 medical providers in Maryland.

See all medical providers in Maryland

Medicare billing

Part B allowed, 2024
$79,050
Medicare patients
323
Services billed
1,219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban44$54,238
OzempicSemaglutide17$24,535
JardianceEmpagliflozin13$22,076
XareltoRivaroxaban14$16,278
MounjaroTirzepatide11$11,014
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,056
MyrbetriqMirabegron13$5,734
Breo ElliptaFluticasone/Vilanterol11$5,022
Rosuvastatin Calcium90$3,972
Atorvastatin Calcium260$3,324
Fenofibrate18$2,668
Esomeprazole Magnesium17$2,643
Fluticasone Propionate HfaFluticasone Propionate11$2,575
Ezetimibe39$1,806
Levothyroxine Sodium168$1,801

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$55$54,23844 claims
Novo NordiskOzempic$21$24,53517 claims
GSKTrelegy Ellipta, Breo Ellipta$88$14,07825 claims
Lilly USA, LLCMounjaro$165$11,01411 claims
Astellas Pharma US IncMyrbetriq$35$5,73413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 543 medical providers in Maryland.

Other medical in Berlin

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →